Super-Enhancer Clustering for Gene Expression Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies lack effective methods to modulate the expression of cell type-specific genes required for maintaining embryonic stem cell identity or disease states, such as cancer, as the mechanisms underlying regulatory elements' contribution to these processes are not fully understood.
Innovation Solution
The development of isolated super-enhancers and related compositions that include genomic regions with clustered enhancers, occupied by higher levels of transcriptional coactivators and chromatin regulators, to drive high expression of specific genes, along with methods to identify and disrupt aberrantly expressed genes associated with super-enhancers using agents like BRD4 inhibitors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If super-enhancers with clustered enhancers are used to drive high expression of cell type-specific genes, then gene expression level is improved, but device complexity increases due to the need for multiple enhancer elements and higher order genomic structures
Solution Approach 1:
The patent combines multiple enhancer elements into a single super-enhancer structure that functions as one integrated regulatory unit. This merging of multiple functional elements (enhancers, transcription factor binding sites, chromatin regulator sites) creates a coordinated system that drives high-level gene expression while managing the complexity through functional integration rather than separate discrete elements
2Productivity
If higher levels of transcriptional coactivators and chromatin regulators are recruited to super-enhancers, then gene expression is enhanced, but loss of substance increases due to the sequestration and depletion of these regulatory proteins from other genomic locations
Solution Approach 1:
The super-enhancer structure creates a localized zone of high transcriptional activity with concentrated coactivators and chromatin regulators. This local quality enhancement allows high gene expression at the super-enhancer locus while the recruited proteins can be replenished from the nuclear pool, as the sequestration is spatially and functionally localized rather than globally depleting cellular resources
3Object-affected harmful factors
If agents like BRD4 inhibitors are used to disrupt aberrantly expressed genes associated with super-enhancers, then harmful factors are reduced, but device complexity increases due to the need for specific pharmacological interventions
Solution Approach 1:
The patent employs small molecule inhibitors (such as BRD4 inhibitors) as intermediary agents that specifically target and disrupt the interaction between chromatin regulators and super-enhancer DNA. These intermediaries provide a controllable, reversible means to inhibit aberrant gene expression without requiring complex genetic or cellular manipulation, simplifying the therapeutic approach while maintaining specificity
Data Source
AI summary
The present invention relates in some aspects to super-enhancers and related compositions, methods, and agents that are useful for modulating expression of cell type-specific genes that are required for maintenance of cell identity (e.g., embryonic stem cell identity) or maintenance of a disease state (e.g., cancer).